Back
Hims & Hers Health Quote, Financials, Valuation and Earnings
Sponsored
HIMS
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
28
HIMS
Hims & Hers Health
Last Price:
12.50
Seasonality Move:
-5.51%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereHims & Hers Health Price Quote
$12.50
-0.01 (-0.24%)
(Updated: May 2, 2024 at 6:05 AM ET)
Hims & Hers Health Key Stats
Sell
28
Hims & Hers Health (HIMS)
is a Sell
Day range:
$12.19 - $13.16
52-week range:
$5.65 - $17.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.00
P/B ratio:
7.79%
Volume:
4.8M
Avg. volume:
4.4M
1-year change:
4.08%
Market cap:
$2.7B
Revenue:
$872M
EPS:
$-0.11
How Much Does Hims & Hers Health Make?
-
How Much Are Hims & Hers Health's Sales Annually?
HIMS Revenues are $872M -
How Much Profit Does Hims & Hers Health's Make A Year?
HIMS net income is -$23.5M
Is Hims & Hers Health Growing As A Company?
-
What Is Hims & Hers Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.47% -
What Is Hims & Hers Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Hims & Hers Health Stock Price Performance
-
Did Hims & Hers Health Stock Go Up Last Month?
Hims & Hers Health share price went down by -20.11% last month -
Did HIMS's Share Price Rise Over The Last Year?
HIMS share price rose by 4.08% over the past 1 year
What Is Hims & Hers Health 52-Week High & Low?
-
What Is Hims & Hers Health’s 52-Week High Share Price?
Hims & Hers Health has traded as high as $17.16 over the past 52 weeks -
What Is Hims & Hers Health’s 52-Week Low Share Price?
Hims & Hers Health has traded as low as $5.65 over the past 52 weeks
Hims & Hers Health Price To Free Cash Flow
-
Is Hims & Hers Health Stock Overvalued?
Hims & Hers Health is trading at a price to free cash flow ratio of 55.73 -
Is Hims & Hers Health Stock Undervalued?
Hims & Hers Health EV to Free Cash Flow ratio is 52.34 -
What Is Hims & Hers Health’s Price Earnings Growth Ratio?
HIMS PEG ratio is 0.00 -
Is Hims & Hers Health Trading At A Premium To Earnings?
Hims & Hers Health EV to EBIT ratio is 0.00
Is It Risky To Buy Hims & Hers Health?
-
How Much Debt Does Hims & Hers Health Have?
Total long term debt quarterly is $0 -
How Much Cash Does Hims & Hers Health Have?
Cash and short term investments quarterly total is $221M -
What Is Hims & Hers Health’s Book Value Per Share?
Book value per share is 1.61
Is Hims & Hers Health Cash Flow Positive?
-
What Is HIMS Cash Flow From Operations?
Cash flow from operations (TTM) is $73.5M -
What Is Hims & Hers Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$11.5M -
What Is Hims & Hers Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$12.1M
Hims & Hers Health Return On Invested Capital
-
Is Management Doing A Good Job?
HIMS return on invested capital is -7.28% -
What Is Hims & Hers Health Return On Assets?
ROA measures how assets are converting to revenues and is -5.92% -
What Is HIMS Return On Equity?
ROE is a measure of profitability and is -7.28%
Hims & Hers Health Earnings Date & Stock Price
-
What Is Hims & Hers Health's Stock Price Today?
A single share of HIMS can be purchased today for 12.51 -
What Is Hims & Hers Health’s Stock Symbol?
Hims & Hers Health trades on the nyse under the ticker symbol: HIMS -
When Is Hims & Hers Health’s Next Earnings Date?
The next quarterly earnings date for Hims & Hers Health is scheduled on May 6, 2024 -
When Is HIMS's next ex-dividend date?
Hims & Hers Health's next ex-dividend date is May 2, 2024 -
How To Buy Hims & Hers Health Stock?
You can buy Hims & Hers Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Hims & Hers Health Competitors
-
Who Are Hims & Hers Health's Competitors?
Below is a list of companies who compete with Hims & Hers Health or are related in some way:
Hims & Hers Health Dividend Yield
Data Unavailable
Hims & Hers Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -16.07% |
Revenue: | 47.5% | 0.06% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 15.52 |
Upside from Last Price: | 24.04% |